Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.38 |
| ▸ | KCNA3 | P22001 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | DRD2 | P14416 | 1/20 | 0.34 |
| ▸ | DRD4 | P21917 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4482561 | 0.84 | ALDH1A1 (0.51) | ALDH1A1TSHRHTTKMT2ASMN1; SMN2 | |
| SCHEMBL10624241 | 0.78 | ALDH1A1 (0.48) | ALDH1A1TSHRHTTKMT2ASMN1; SMN2 | |
| SCHEMBL734030 | 0.77 | KCNN4 (0.42) | ALDH1A1TSHRHTTKMT2ASMN1; SMN2 | |
| SCHEMBL8031704 | 0.76 | ALDH1A1 (0.43) | ALDH1A1TSHRHTTKMT2ASMN1; SMN2 | |
| SCHEMBL8031703 | 0.76 | ALDH1A1 (0.43) | ALDH1A1TSHRHTTKMT2ASMN1; SMN2 | |
| SCHEMBL8031705 | 0.76 | ALDH1A1 (0.43) | ALDH1A1TSHRHTTKMT2ASMN1; SMN2 | |
| SCHEMBL14996084 | 0.74 | KCNA3 (0.40) | ALDH1A1TSHRKCNN4KCNA3MAPT | |
| SCHEMBL2636117 | 0.74 | SMN1; SMN2 (0.46) | ALDH1A1KMT2ASMN1; SMN2MEN1KCNA3 | |
| SCHEMBL19145997 | 0.73 | ALDH1A1 (0.42) | ALDH1A1TSHRHTTKMT2ASMN1; SMN2 | |
| SCHEMBL4493385 | 0.73 | ALDH1A1 (0.49) | ALDH1A1HTTKMT2ASMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7619086-B2 | HIV integrase inhibitors | MERCK & CO., INC. (US) | 2009-11-17 | — | — | US | disclosed |
| US-20080139579-A1 | Hiv Integrase Inhibitors | MERCK & CO., INC. (US) | 2008-06-12 | — | — | US | disclosed |
| EP-1725535-A2 | HIV INTEGRASE INHIBITORS | Merck & Co., Inc. (US) | 2006-11-29 | — | — | EP | disclosed |
| WO-2005086700-A2 | HIV INTEGRASE INHIBITORS | MERCK & CO., INC. (US) | 2005-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080139579-A1 | Hiv Integrase Inhibitors | INTS9, CDK9, PRDM9 | ALDH1A1 3596/4885TSHR 2545/4885HTT 4764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.